Nutra Pharma Corp
NPHC· OTC
NPHCNutra Pharma Corp
Filed Apr 16, 2013 · 10-K · 106 days after period end · 0001144204-13-022247
derived · Computed from the longer spans the company filed.
| Metric | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $158.83K | — | — |
| Net Income | -$2.09M | -$2.50M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Apr 16, 2013 · 106 d after period end
